US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Acasti Pharma Inc (ACST)
Acasti Pharma Inc (ACST) ニュース

ACST

Acasti Pharma (ACST)

Acasti Pharma Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ACST

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/10/28	21 : 22	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ACST	Acasti Pharma Inc
2024/10/25	21 : 13	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ACST	Acasti Pharma Inc
2024/10/16	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:ACST	Acasti Pharma Inc
2024/10/16	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:ACST	Acasti Pharma Inc
2024/10/08	20 : 22	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:ACST	Acasti Pharma Inc
2024/10/08	20 : 16	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:ACST	Acasti Pharma Inc
2024/10/08	20 : 16	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:ACST	Acasti Pharma Inc
2024/10/08	20 : 16	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:ACST	Acasti Pharma Inc
2024/10/08	20 : 15	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:ACST	Acasti Pharma Inc
2024/10/08	20 : 13	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:ACST	Acasti Pharma Inc
2024/10/01	05 : 31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ACST	Acasti Pharma Inc
2024/09/25	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ACST	Acasti Pharma Inc
2024/09/07	05 : 07	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:ACST	Acasti Pharma Inc
2024/08/17	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ACST	Acasti Pharma Inc
2024/08/09	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ACST	Acasti Pharma Inc
2024/08/09	20 : 30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ACST	Acasti Pharma Inc
2024/08/08	05 : 14	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:ACST	Acasti Pharma Inc
2024/08/05	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:ACST	Acasti Pharma Inc
2024/07/31	20 : 22	Edgar (US Regulatory)	Form S-4/A - Registration of securities, business combinations: [Amend]	NASDAQ:ACST	Acasti Pharma Inc
2024/07/12	00 : 16	Edgar (US Regulatory)	Form 3/A - Initial statement of beneficial ownership of securities: [Amend]	NASDAQ:ACST	Acasti Pharma Inc
2024/07/11	10 : 10	Edgar (US Regulatory)	Form SC 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:ACST	Acasti Pharma Inc
2024/07/10	09 : 29	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ACST	Acasti Pharma Inc
2024/05/11	05 : 11	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	NASDAQ:ACST	Acasti Pharma Inc
2024/05/11	05 : 07	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	NASDAQ:ACST	Acasti Pharma Inc
2024/05/09	08 : 19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACST	Acasti Pharma Inc
2024/05/09	08 : 19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACST	Acasti Pharma Inc
2024/05/09	08 : 19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACST	Acasti Pharma Inc
2024/05/09	08 : 18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACST	Acasti Pharma Inc
2024/05/09	08 : 18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACST	Acasti Pharma Inc
2024/02/12	22 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ACST	Acasti Pharma Inc

Showing the most relevant articles for your search:NASDAQ:ACST

1 2 3 4 5 6 7 8 9 10 次へ >>

American Express

Bank of America

Deutsche Telekom (QX)

US Dollar vs Sterling

JP Morgan Chase

US Dollar vs Euro

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約